PS Oluga urges African states to prioritize local vaccine production

The Principal Secretary for Medical Services, Ouma Oluga, has urged increased investment in local vaccine manufacturing and stronger international partnerships to enhance health security.

Addressing a high-level panel at the 78th World Health Assembly (WHA78) hosted by UNITAID, Oluga underscored the key lessons from the COVID-19 pandemic, particularly Africa’s heavy dependence on foreign suppliers for vaccines and protective gear.

He pointed out that disruptions in global supply chains left many African nations at the end of the line for vital medical supplies, highlighting the urgent need for self-reliance through local production.

"The COVID-19 crisis revealed our weaknesses and showed why Africa must build its own manufacturing capacity," Oluga said.

"Investing in domestic production is crucial to guarantee timely access to essential health products and minimize reliance on imports."

The WHA78 discussions reflected a growing agreement on the importance of sustainable and locally led health solutions.

The panel brought together top health officials worldwide to explore ways to strengthen health systems and improve readiness for future health crises.

Oluga emphasized the significance of collaboration, noting that in today’s interconnected world, "working alone is no longer feasible."

He added, "Global cooperation is vital for creating resilient health systems."

Addressing the recently adopted Pandemic Agreement, Oluga called it a groundbreaking framework aimed at boosting global preparedness and addressing disparities in access to critical medical supplies.

"This agreement marks a major milestone in our shared mission to strengthen health systems and guarantee fair access to essential health services," he said.

Kenya has been leading efforts to promote local vaccine manufacturing in Africa, with the Kenya BioVax Institute standing as a clear example of the country’s dedication to expanding vaccine production capacity.

Oluga highlighted that such projects are vital to meeting the African Union’s target of producing 60 percent of the continent’s vaccines by 2040.

"Supporting local manufacturing not only bolsters our health infrastructure but also drives job creation and economic development," Oluga stated.

"It is crucial to harmonize policies and direct investments toward growing the pharmaceutical and biomanufacturing industries."

The WHA78 panel emphasized the importance of strengthening health systems through strategic investments and cooperative actions.

"Now is the moment to act decisively. Together, we can reshape our health systems and secure a healthier future for everyone," said the PS.